Together, these findings indicate that CCL5 deficiency provides a protective effect in ADR-induced nephropathy by reducing albuminuria, glomerular sclerosis, podocyte loss, and foot process effacement, suggesting that CCL5 contributes to the progression of glomerular injury. The gene discussed is CCL5; the disease is kidney disorder.